mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.1 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.1 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.1 |